ALVO
Alvotech
NASDAQ: ALVO · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$3.30
-6.25% today
Updated 2026-04-29
Market cap
$1.03B
P/E ratio
33.00
P/S ratio
1.75x
EPS (TTM)
$0.10
Dividend yield
—
52W range
$3 – $12
Volume
0.6M
Alvotech (ALVO) Financial statements
SEC filings — annual and quarterly data.
Profit margin
4.74%
Operating margin
33.80%
ROE
0.00%
ROA
3.82%
Debt/equity
-7.25x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $31.92M | $-209.88M | 100.00% | -192.52% | -657.55% |
| 2020 | $66.62M | $-170.04M | 100.00% | -206.46% | -255.26% |
| 2021 | $36.77M | $-101.50M | 100.00% | -640.31% | -276.04% |
| 2022 | $83.03M | $-513.58M | 22.80% | -417.25% | -618.55% |
| 2023 | $91.43M | $-551.73M | -75.93% | -388.11% | -603.42% |
| 2024 | $489.68M | $-231.86M | 62.16% | 14.22% | -47.35% |
| 2025 | $586.32M | $27.92M | 59.82% | 13.34% | 4.76% |